4DMedical Ltd ASX: 4DX Share Price & Review

4DX Overview

4DX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Weak

About 4DX

Website

4DMedical Ltd

Telephone

61.3.9545.5940

Address

700 Swanston Street Level 7 Carlton, Victoria (VIC) 3053

Description

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. It develops pipeline products that may assist physicians to more effectively diagnose and manage patients with lung disease, which includes XV ventilation analysis, ventilation perfusion, contrast free pulmonary angiography, small animal ventilator, and preclinical scanner. The company was founded by Andreas Fouras in December 2012 and is headquartered in Carlton, Australia.

4DX Price Chart

Key Stats

Market Cap

AU$225.70M

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.41 - 0.83

Trade Value (12mth)

AU$97,449.00

1 week

10%

1 month

-3.51%

YTD

14.58%

1 year

-12.7%

All time high

2.98

Key Fundamentals

EPS 3 yr Growth

18.60%

EBITDA Margin

Operating Cashflow

-$31m

Free Cash Flow Return

-40.90%

ROIC

-47.70%

Interest Coverage

-167.30

Quick Ratio

1.70

Other Data

Shares on Issue (Fully Dilluted)

410m

HALO Sector

Technology

Next Company Report Date

28-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.22

4DX Announcements

Latest Announcements

Date	Announcements
21 February 25	4DMedical completes Placement & launches underwritten SPP × 4DMedical completes Placement & launches underwritten SPP
21 February 25	INVESTOR PRESENTATION - CAPITAL RAISE × INVESTOR PRESENTATION - CAPITAL RAISE
21 February 25	Webinar Details - Capital Raise × Webinar Details - Capital Raise
29 January 25	Quarterly Activity Report and Appendix 4C for Q2 FY2025 × Quarterly Activity Report and Appendix 4C for Q2 FY2025
24 January 25	4DMedical progresses to a commercial agreement with Qscan × 4DMedical progresses to a commercial agreement with Qscan
24 January 25	Application for quotation of securities - 4DX × Application for quotation of securities - 4DX
17 January 25	Notification regarding unquoted securities - 4DX × Notification regarding unquoted securities - 4DX
17 January 25	Application for quotation of securities - 4DX × Application for quotation of securities - 4DX
17 January 25	Change of Director's Interest Notice × Change of Director's Interest Notice
17 January 25	Change of Director's Interest Notice × Change of Director's Interest Notice
17 January 25	Change of Director's Interest Notice × Change of Director's Interest Notice
17 January 25	Change of Director's Interest Notice × Change of Director's Interest Notice
17 January 25	Change of Director's Interest Notice × Change of Director's Interest Notice
15 January 25	Notification of cessation of securities - 4DX × Notification of cessation of securities - 4DX
13 January 25	US DoD to conduct paid CT VQ pilot ahead of FDA submission × US DoD to conduct paid CT VQ pilot ahead of FDA submission
08 January 25	Application for quotation of securities - 4DX × Application for quotation of securities - 4DX
07 January 25	4DMedical receives U.S. FDA clearance for IQ-UIP × 4DMedical receives U.S. FDA clearance for IQ-UIP
20 December 24	Director change to non-executive role × Director change to non-executive role
20 December 24	Application for quotation of securities - 4DX × Application for quotation of securities - 4DX
20 December 24	Cleansing Notice × Cleansing Notice
16 December 24	4DMedical wins contract with University of Chicago Medicine × 4DMedical wins contract with University of Chicago Medicine
04 December 24	4DMedical unveils CT VQ at RSNA 2024 × 4DMedical unveils CT VQ at RSNA 2024
02 December 24	4DMedical signs contract to expand in Western Australia × 4DMedical signs contract to expand in Western Australia
29 November 24	Application for quotation of securities - 4DX × Application for quotation of securities - 4DX
25 November 24	4DMedical wins commercial contract with IPOC × 4DMedical wins commercial contract with IPOC

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Falling Divs over next 2

Values and Recommendations

Key Stats

Consensus Score

Recommendation

EPS 1 month Change

Quality Yield

Falling Divs over next 2

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

Percent of Issue

0.22%

Value ($M)

0

Prior Change

N/A

7 Day Change

0.10%

1 Month Change

0.10%

3 Month Change

0.10%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

4DX Shortsell

Frequently Asked Questions

What is the current share price of 4DMedical Ltd (4DX:ASX)?

The current share price of 4DMedical Ltd (4DX:ASX) is AU$0.44.

What is the 52-week high share price for 4DMedical Ltd (4DX:ASX)?

The 52-week high share price for 4DMedical Ltd (4DX:ASX) is AU$0.83.

What is the 52-week low share price for 4DMedical Ltd (4DX:ASX)?

The 52-week low share price for 4DMedical Ltd (4DX:ASX)? is AU$0.41.

What is the dividend yield for 4DMedical Ltd (4DX:ASX)?

4DMedical Ltd (4DX:ASX) does not pay a dividend.

What was 4DMedical Ltd (4DX:ASX) last dividend payment?

4DMedical Ltd (4DX:ASX) does not pay a dividend.

What is the franking level for 4DMedical Ltd (4DX:ASX)?

4DMedical Ltd (4DX:ASX) has a franking level of 0.0%.

In which sector is 4DMedical Ltd (4DX:ASX) classified?

4DMedical Ltd (4DX:ASX) is classified in the Technology.

The current P/E ratio for 4DMedical Ltd (4DX:ASX) is .

Company

Important

Get the latest insights and hot tips delivered right to your inbox

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.

4DX · ASX

4DMedical Ltd (ASX:4DX)

AU$0.44

4DX Overview

4DX Health Scores

About 4DX

4DX Price Chart

Key Stats

AU$225.70M

N/A

N/A

Dividends Overview

N/A

N/A

N/A

Market Data

Key Fundamentals

Other Data

4DX Announcements

Latest Announcements

4DMedical completes Placement & launches underwritten SPP

INVESTOR PRESENTATION - CAPITAL RAISE

Webinar Details - Capital Raise

Quarterly Activity Report and Appendix 4C for Q2 FY2025

4DMedical progresses to a commercial agreement with Qscan

Application for quotation of securities - 4DX

Notification regarding unquoted securities - 4DX

Application for quotation of securities - 4DX

Change of Director's Interest Notice

Change of Director's Interest Notice

Change of Director's Interest Notice

Change of Director's Interest Notice

Change of Director's Interest Notice

Notification of cessation of securities - 4DX

US DoD to conduct paid CT VQ pilot ahead of FDA submission

Application for quotation of securities - 4DX

4DMedical receives U.S. FDA clearance for IQ-UIP

Director change to non-executive role

Application for quotation of securities - 4DX

Cleansing Notice

4DMedical wins contract with University of Chicago Medicine

4DMedical unveils CT VQ at RSNA 2024

4DMedical signs contract to expand in Western Australia

Application for quotation of securities - 4DX

4DMedical wins commercial contract with IPOC

Dividends

Key Stats

N/A

N/A

N/A

N/A

Values and Recommendations

Key Stats

Halo Consensus Score

PEG Ratio

Consensus EPS Revisions

Short selling

Key Stats

0.22%

0

N/A

0.10%

0.10%

0.10%

Discover Short-sellingOpportunities

4DX Shortsell

Related Companies

Frequently Asked Questions

Company

Company

Important

Discover
Short-selling
Opportunities